|
US2005048102A1
|
|
Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
|
|
AU8938501A
|
|
Compositions and methods for topical application of therapeutic agents
|
|
AU3892401A
|
|
Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
|
|
CA2329128A1
|
|
Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
|
|
EP0987019A1
|
|
Topical antibiotic composition for rapid wound healing
|
|
CA2246773A1
|
|
Topical antibiotic composition providing optimal moisture environment for rapid wound healing that reduces skin contraction
|
|
US5800832A
|
|
Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
|
|
US5955097A
|
|
Pharmaceutical preparation applicable to mucosal surfaces and body tissues
|
|
US5863560A
|
|
Compositions and methods for topical application of therapeutic agents
|
|
US5762917A
|
|
Method and composition for cleansing wounds with minimal cytotoxicity for minimal scarring
|
|
WO9609759A1
|
|
Non-cytotoxic wound-cleansing compositions
|
|
WO9609829A1
|
|
Improved topical carriers for mucosal applications
|
|
US5631301A
|
|
Topical antibiotic composition providing optimal moisture environment
|
|
US5380754A
|
|
Topical composition enhancing healing of viral lesions
|
|
AU653248B2
|
|
Topical composition enhancing healing of herpes lesions
|
